drugset / Trial / NCT03344614
A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
30 patients with advanced colorectal cancer will be enrolled to observe the efficacy and safety of raltitrexed combined with apatinib as a third-line treatment.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2019-01-01
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Raltitrexed | Small molecule | 3 mg/m2 | Intravenous |
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |